Startseite IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome

  • Elena Mattia EMAIL logo , Amelia Ruffatti , Marta Tonello , Lauro Meneghel , Bianca Robecchi , Marina Pittoni , Nicoletta Gallo , Elisa Salvan , Vera Teghil , Leonardo Punzi und Mario Plebani
Veröffentlicht/Copyright: 21. März 2014
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: Primary antiphospholipid syndrome (PAPS) is an autoimmune disease characterized by thrombosis and/or pregnancy morbidity as well as blood antiphospholipid (aPL) antibodies such as anticardiolipin (aCL), anti-β2 glycoprotein I (anti-β2GPI) antibodies of the IgG/IgM isotype and lupus anticoagulant (LA). The clinical significance of aCL and anti-β2GPI antibodies of the IgA isotype in PAPS is still a controversial issue.

Methods: Sera and plasma were collected from 84 PAPS patients (54 with thrombosis and/or pregnancy morbidity and 30 with pregnancy morbidity alone), 66 seronegative patients (subjects with clinical manifestations of PAPS although with negative results on conventional antiphospholipid antibody testing), and 78 healthy blood donors. IgA aCL and IgA anti-β2GPI were determined using fluorescence enzyme immunoassay (FEIA), (EliATM, Phadia AB, Uppsala, Sweden). For comparison purposes, the sera were also tested for IgG/IgM aCL/anti-β2GPI antibodies using the same immunoassay method. LA was assayed following internationally accepted guidelines.

Results: Present respectively in 19% and 50% of the PAPS patients studied, IgA aCL and IgA anti-β2GPI antibody frequencies were both statistically significant (p=0.001 and p<0.001, respectively). The mean titers of both IgA aCL and IgA anti-β2GPI antibodies were higher in the thrombotic patients, but only the latter were significantly associated with thrombosis. Isolated IgA anti-β2GPI antibody positivity was significantly prevalent (p=0.04) in seven (10.6%) of the seronegative patients.

Conclusions: Positivity to IgA anti-β2GPI antibody detected using FEIA was found to be clinically relevant in PAPS patients. Moreover the prevalence of isolated IgA anti-β2GPI antibody positivity was significant in the seronegative patients.


Corresponding author: Elena Mattia, Rheumatology Unit, Department of Medicine, University of Padua, Via Giustiniani 2, 35128 Padua, Italy, Phone: +39 049 8218397, Fax: +39 049 8212191, E-mail:

Conflict of interest statement

Authors’ conflict of interest disclosure: The authors declare that there are no conflicts of interest regarding this article.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

References

1. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295–306.10.1111/j.1538-7836.2006.01753.xSuche in Google Scholar

2. Pengo V, Biasiolo A, Pegoraro C, Cucchini U, Noventa F, Iliceto S. Antibody profiles for the diagnosis of antiphospholipid syndrome. Thromb Haemost 2005;93:1147–52.10.1160/TH04-12-0839Suche in Google Scholar

3. Ruffatti A, Tonello M, Del Ross T, Cavazzana A, Grava C, Noventa F, et al. Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity. Thromb Haemost 2006;96:337–41.10.1160/TH06-05-0287Suche in Google Scholar

4. Carmo-Pereira S, Bertolaccini ML, Escudero-Contresas A, Khamashta MA, Hughes GR. Value of IgA anticardiolipin and anti-β2-glycoprotein I antibody testing in patients with pregnancy morbidity. Ann Rheum Dis 2003;62: 540–3.10.1136/ard.62.6.540Suche in Google Scholar

5. Samarkos M, Davies KA, Gordon C, Loizou S. Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Clin Rheumatol 2006;25:199–204.10.1007/s10067-005-1156-zSuche in Google Scholar

6. Meijide H, Sciascia S, Sanna G, Khamashta MA, Bertolaccini ML. The clinical relevance of IgA anticardiolipin and IgA anti-β2 glycoprotein I antiphospholipid antibodies. A systemic review. Autoimmun Rev 2012;12:421–5.10.1016/j.autrev.2012.08.002Suche in Google Scholar

7. Andreoli L, Fredi M, Nalli C, Piantoni S, Reggia R, Dall’Ara F, et al. Clinical significance of IgA anti-Cardiolipin and IgA anti-β2 glycoprotein I antibodies. Curr Rheumatol Rep 2013;15:343–51.10.1007/s11926-013-0343-1Suche in Google Scholar

8. Abinader H, Hanly AJ, Lozada CJ. Catastrophic antiphospholipid syndrome associated with anti-beta-2-glycoprotein I IgA. Rheumatology (Oxford) 1999;38:84–5.10.1093/rheumatology/38.1.84Suche in Google Scholar

9. Yamada H, Tsutsumi A, Ichikawa K, Kato EH, KoikeT, Fujimoto S. IgA-class anti- β2glycoprotein I in women with unexplained recurrent spontaneous abortion. Arthritis Rheum 1999;42:2727–30.10.1002/1529-0131(199912)42:12<2727::AID-ANR33>3.0.CO;2-QSuche in Google Scholar

10. Lee RM, Branch DW, Silver RM. Immunoglobulin A anti-β2glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion. Am J Obstet Gynecol 2001;185:748–53.10.1067/mob.2001.117659Suche in Google Scholar

11. Ranzolin A, Bohn JM, Norman GL, Manenti E, Bodanese LC, von Mühlen CA, et al. Anti-β2glycoprotein I antibodies as risk factors for acute myocardial infarction. Arquivos Brasileiros de Cardiologia 2004;83:141–4.Suche in Google Scholar

12. Kahles T, Humpich M, Steinmetz H, Sitzer M, Lindhoff-Last E. Phosphatidylserine IgG and β2glycoprotein I IgA antibodies may be a risk factor for ischemic stroke. Rheumatology 2005;44:1161–5.10.1093/rheumatology/keh698Suche in Google Scholar PubMed

13. Kumar S, Papalardo E, Sunkureddi P, Najam S, Gonzáles EB, Pierangeli SS. Isolated elevation of IgA anti-β2 glycoprotein I antibodies with manifestations of antiphospholipid syndrome: a case series of five patients. Lupus 2009;18:1011–4.10.1177/0961203309103048Suche in Google Scholar PubMed

14. Murthy V, Willis R, Romany-Penabad Z, Ruiz-Limon P, Martinez-Martinez LA, Jatwani S, et al. Value of isolated IgA anti-β2GPI in the diagnosis of the antiphospholipid syndrome. Arthritis Rheum 2013;65:3186–93.10.1002/art.38131Suche in Google Scholar PubMed PubMed Central

15. Pierangeli SS, Liu XW, Barker JH, Anderson G, Harris EN. Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with antiphspholipid syndrome. Thromb Haemost 1995;74:1361–7.10.1055/s-0038-1649940Suche in Google Scholar

16. Ruiz-Limon P, Romany-Penabad Z, Carrera Marin AL, Papalardo E, Pierangeli SS. IgA anti-β2glycoprotein I antibodies are pathogenetic in a mouse model of APS. Arthritis Rheum 2012;64:S742.Suche in Google Scholar

17. Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M, et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2009;7:1737–40.10.1111/j.1538-7836.2009.03555.xSuche in Google Scholar PubMed

18. Villalta D, Alessio MG, Tampoia M, Da Re A, Stella S, Da Re M, et al. Accuracy of the first fully automated method for anti-cardiolipin anti-beta2 glycoprotein I antibody detection for the diagnosis of antiphospholipid syndrome. Ann N Y Acad Sci 2009;1173:21–7.10.1111/j.1749-6632.2009.04659.xSuche in Google Scholar PubMed

19. Forastiero R, Papalardo E, Watkins M, Nguyen H, Quirbach C, Jaskal K, et al. Evaluation of different immunoassay for the detection of antiphospholipid antibodies: Report of a wet workshop during the 13th International Congress on Antiphospholipid Antibodies. Clin Chim Acta 2014;428:99–105.10.1016/j.cca.2013.11.009Suche in Google Scholar PubMed

20. Bozic B, Cucnik S, Gaspersic N, Ambrozic A, Kveder T, Rozman B. Rational laboratory diagnostics of antiphospholipid antibodies: anti-cardiolipin, anti-β2-glycoprotein I, anti-prothrombin and anti-annexin V antibodies. eJIFCC 2009;20:1–8.Suche in Google Scholar

21. Bertolaccini ML, Amengual O, Atsumi T, Binder WL, de Laat B, Forastiero R, et al. “Non-criteria” aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010. Lupus 2011;20:191–205.10.1177/0961203310397082Suche in Google Scholar PubMed

Received: 2014-1-10
Accepted: 2014-2-28
Published Online: 2014-3-21
Published in Print: 2014-9-1

©2014 by De Gruyter

Artikel in diesem Heft

  1. Frontmatter
  2. Editorial
  3. Red blood cell distribution width (RDW) and human pathology. One size fits all
  4. Reviews
  5. LC-MS candidate reference methods for the harmonisation of parathyroid hormone (PTH) measurement: a review of recent developments and future considerations
  6. C-reactive protein and migraine. Facts or speculations?
  7. Mini Review
  8. ABO blood group and von Willebrand factor: biological implications
  9. Genetics and Molecular Diagnostics
  10. Lactase persistence genotyping: rapid detection of seven sequence variants in a single tube with melting curve analyses
  11. General Clinical Chemistry and Laboratory Medicine
  12. The 3rd International Standard for serum IgE: international collaborative study to evaluate a candidate preparation
  13. Improving CardioCheck PA analytical performance: three-year study
  14. Serum copeptin level predicts a rapid decrease of overhydration after kidney transplantation
  15. Thyroid function and thyroid autoimmunity in apparently healthy pregnant and non-pregnant Mexican women
  16. Serum and follicular fluid fetuin-A in women undergoing in vitro fertilization
  17. Value of reelin for assessing hepatic fibrogenesis in a group of Egyptian HCV infected patients
  18. IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome
  19. Reference Values and Biological Variations
  20. Serum glucose adjusted cut-off values for normal cerebrospinal fluid/serum glucose ratio: implications for clinical practice
  21. Age- and gender-specific brain natriuretic peptide (BNP) reference ranges in primary care
  22. Cancer Diagnostics
  23. Clinical utility of %p2PSA and prostate health index in the detection of prostate cancer
  24. Clinical prognostic value of CD4+CD25+FOXP3+regulatory T cells in peripheral blood of Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma patients
  25. Increased expression of carbonic anhydrase IX in oral submucous fibrosis and oral squamous cell carcinoma
  26. Cardiovascular Diseases
  27. Ideal cardiovascular health behaviors and factors and high sensitivity C-reactive protein: the Kailuan cross-sectional study in Chinese
  28. Letters to the Editor
  29. Red cell distribution width predicts chronic thromboembolic pulmonary hypertension in patients with acute pulmonary embolism in a long-term follow-up
  30. Red blood cell distribution width is significantly associated with aging and gender
  31. Red blood cell distribution width: a potential prognostic index for liver disease?
  32. Serum folate and vitamin B12: does light really matter?
  33. Thalassemia diagnosis in a blood donor from a unique trimorphic red blood cell population observed in the recipient
  34. A preliminary study on serum proteomics in fibromyalgia syndrome
  35. First study of angiotensin converting enzyme in cystic fibrosis Tunisian patients
  36. FlashFISH™: a novel technique for rapid diagnosis of aneuploidies in dysmorphic neonates
  37. Determination of the amniotic fluid lecithin/sphingomyelin ratio using a pipette tip column with a cation-exchange resin and mass spectrometry
  38. Congress Abstracts
  39. 57th National Congress of the Hungarian Society of Laboratory Medicine
Heruntergeladen am 24.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2014-0039/html
Button zum nach oben scrollen